Stay updated with breaking news from Initial Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As part of its ongoing efforts to increase inclusivity towards non-native English speakers in the academic setting, the Illinois State Board of Education amended its special education...
The mission of the Northeast Sight Services is to help blind and visually impaired individuals achieve the best possible quality of life by providing…
The Texas Education Agency announced last month it wanted to install conservators to oversee special education services in the district. The proposal came after an investigation that found AISD repeatedly failed to meet the needs of students with disabilities.
Avacta Group is developing novel cancer immunotherapies and powerful diagnostics based on its two proprietary platforms - Affimer ® biologics and pre|CISION™ tumour targeted chemotherapies. The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets, such as diagnostics and therapeutics, worth in excess of $100bn. Affimer technology has been designed to address many of these negative performance issues, principally: the time taken to generate new antibodies and the reliance ...